USA |NASDAQ |USD
Revenues were $903.38K, down by -10.31% from previous year's revenue.
The company reported a net income of $-8.94M.
Cyclo Therapeutics reported a free cash flow of $-8.59M for its fiscal year, compared to $-6.59M a year ago.
The company ended the fiscal year with $194.44K in total debt, an increase of 270.29% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.